The UK-China Health and Economy Partnership
- Group summary: The UK-China Health and Economy Partnership (UK-CHEP) promotes long-term collaboration in health economics and Health Technology Assessment for the mutual benefit of leading academic institutions in the UK and China, which has been funded by GlaxoSmithKline (GSK) and is overseen by the British Council.
This is a novel knowledge transfer partnership between both countries and the partner institutions. The University of Leeds who are partnered with Zhejiang University, Hangzou are working in collaboration with Bournemouth University, University of York, University of Sheffield in the UK and Fudan University and Shandong University in China.
Health Economics of Diagnostic Tests and Screening Programmes Masterclass
23rd & 24th March 2021
In March, the University of Leeds and Zhejiang University masterclass took place in person at Zhejiang University and online throughout China and the UK.
Read more about the masterclass event.
UK-CHEP short summary
The UK-China Health and Economy Partnership is a novel knowledge transfer partnership that will promote long-term collaboration between University of Leeds, Bournemouth University, University of York and University of Sheffield in the UK and Zhejiang University, Fudan University and Shandong University in China.
The partnership aims to create long-term, sustainable collaboration in health economics, which will give UK and Chinese academics the means to work together on world-class educational and research outcomes that would otherwise not be possible working in isolation.
This partnership was originally launched in Jinan, Shandong province in November 2017 by Bournemouth University. GlaxoSmithKline and the British Council have extended the partnership for a further two years, from January 2019.
Read more about the partnership.
Masterclass Summary
The masterclass will explore the key health economic arguments surrounding the implementation of diagnostic tools and screening programmes, demonstrating how concepts of sensitivity and specificity and prevalence fit within the internationally recognised economic evaluation framework used for more traditional treatments.
Presentations will be given by leading experts in health economics and diagnostic and screening evaluation methodologies and the sessions will be chaired by Partnership Leads, Professors Hengjin Dong (Zhejiang University) and Chris Bojke (University of Leeds).
The presenters are:
- Gill Caldicott, British Council
- Jenny Wu, GlaxoSmithKline (China)
- Min Li,Zhejiang university
- Dr. Xuemei Zhen, Shandong University
-
Dr Zixuan Zhao, Zhejiang University
Speaker Biographies
of Leeds. Alison recently finished her PhD, in which she explored the role of test measurement uncertainty (bias and imprecision) on the clinical and cost-effectiveness of testing strategies. She sits on the NIHR Leeds In Vitro Diagnostics Co-operative, and is an expert member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Test Evaluation Working Group.
Download the full event programme document
Masterclass Timetable
23 March 2021 - Day 1
China time |
UK time |
Title |
Presenter |
15:20
|
08:20 |
Welcome |
Gill Caldicott, British Council; Jenny Wu, GlaxoSmithKline (China); Dr, Min Li, International Cooperation, Zhejiang University; Prof Darrin Baines, Bournemouth University; Prof Hengjin Dong, Zhejiang University |
15:40 |
08:40 |
Introduction to the Economic Evaluation of Tests |
Prof Chris Bojke, University of Leeds |
16:40 |
09:40 |
Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis |
Prof Shuyan Gu, Nanjing University |
17:20 |
10:20 |
Coffee break |
|
17:30 |
10:30 |
Economic evaluation of Esophageal cancer screening in China |
Prof Hengjin Dong. Zhejiang University |
18:00 |
11:00 |
Discussion |
Lead by Prof Hengjin Dong, Zhejiang University |
18:10 |
11:10 |
Summary |
Prof Chris Bojke, University of Leeds |
18:30 |
11:30 |
Dinner |
|
24 March 2021 - Day 2
China time |
UK time |
Title |
Presenter |
09:30 |
02:30 |
Welcome |
Prof Hengjin Dong, Zhejiang University |
09:40
|
02:40 |
Decision analytic models for tests |
Dr. Alison Smith, University of Leeds |
10:20 |
03:20 |
Decision modeling for economic evaluation for CAR-T cell therapy products |
Dr. Weijia Wu, Zhejiang University |
10:50 |
03:50 |
Coffee break |
|
11:00 |
04:00 |
Public preferences on lung cancer screening in rural China |
Dr. Zixuan Zhao, Zhejiang University |
11:30 |
04:30 |
Discussion |
Lead by Prof Hengjin Dong, Zhejiang University |
11:40 |
04:40 |
Dinner |
|
15:00 |
08:00 |
Economic burden of antibiotic resistance in China: a national level estimate for inpatients |
Dr. Xuemei Zhen, Shandong University |
15:30 |
08:30 |
Welcome |
Prof Chris Bojke, University of Leeds |
15:40
|
08:40 |
Thinking beyond accuracy |
Dr. Bethany Shinkins, University of Leeds |
16:30 |
09:30 |
Coffee break |
|
16:40 |
09:40 |
Cost effectiveness of drugs managing osteoarthritis in China |
Dr. Xueshan Sun, Zhejiang University |
17:20 |
10:20 |
Discussion |
Lead by Bethany Shinkins, University of Leeds |
18:00 |
11:00 |
Summary |
Prof Chris Bojke, University of Leeds Prof Hengjin Dong, Zhejiang University |
18:20 |
11:20 |
Dinner |